The University of Washington created the Pharmaceutical Outcomes Research and Policy Program (PORPP) in 1995 to coordinate research and graduate training efforts among faculty with an interest in health outcomes and policy research on pharmaceuticals, biopharmaceuticals and other health care technology. Program faculty and professional staff provide medical facilities, health insurance providers, pharmaceutical and device companies and governmental agencies with analyses on the safety and cost-effectiveness of prescription drugs in order to achieve a better understanding of the risks and benefits of medical and pharmaceutical interventions. PORPP has helped the UW become a nationally recognized center for pharmacoepidemiology, pharmacoeconomics, and pharmaceutical policy research.

Mission of the Program

• Conduct research on the effects and uses of pharmaceuticals in human populations.
• Provide graduate and postgraduate training in pharmaceutical outcomes research and policy.
• Disseminate timely information regarding pharmaceutical outcomes research and policies to government, the pharmaceutical industry, health care providers and the general public.
• Inform, through research and scholarship, regional and national policies governing pharmaceuticals and pharmaceutical services.
• Be considered a resource for industry research, consultation and training partnerships.

Program Director 
Sean D. Sullivan, PhD, Professor
Email: 

Associate Director
Louis Garrison, PhD, Professor
Email: 

Administrative Staff
Penny L. Evans, Program Operations Specialist
Email: 

Pharmacy Home || Applying To The School || Contact Us

©2003-2007 University of Washington School of Pharmacy

This page was last updated November 27, 2007